1. Home
  2. List
Reference Patent

Reference - List

  • 85 Hits
  • Search Condition : Filter (MeSH = Cisplatin / pharmacology)
Species Resource Title
DNA material pCMV-VSV-G-RSV-Rev (RDB04393) , pCAG-HIVgp (RDB04394) The novel ZEB1-upregulated protein PRTG induced by Helicobacter pylori infection promotes gastric carcinogenesis through the cGMP/PKG signaling pathway.
Human and Animal Cells HuCCT1(RCB1960) BEX2 is required for maintaining dormant cancer stem cell in hepatocellular carcinoma.
Human and Animal Cells Meth-A(RCB0464) Requirement of the acquired immune system in successful cancer chemotherapy with cis-diamminedichloroplatinum (II) in a syngeneic mouse tumor transplantation model.
Prokaryotes E. coli Keio collection Developing novel antimicrobials by combining cancer chemotherapeutics with bacterial DNA repair inhibitors
Human and Animal Cells Meth-A(RCB0464) Roles of the ribosomal protein S19 dimer and chemically induced apoptotic cells as a tumor vaccine in syngeneic mouse transplantation models.
Human and Animal Cells TE-5(RCB1949) , TE-6(RCB1950) The tumor cell-intrinsic cGAS-STING pathway is associated with the high density of CD8+ T cells after chemotherapy in esophageal squamous cell carcinoma.
Human and Animal Cells T24(RCB0431) Inhibition of aldo-keto reductase 1C3 overcomes gemcitabine/cisplatin resistance in bladder cancer.
Human and Animal Cells TE-1(RCB1894) , TE-4(RCB2097) , TE-5(RCB1949) , TE-6(RCB1950) , TE-8(RCB2098) , TE-9(RCB1988) , TE-10(RCB2099) , TE-11(RCB2100) , TE-14(RCB2101) , TE-15(RCb1951) Cetuximab inhibits cisplatin-induced activation of EGFR signaling in esophageal squamous cell carcinoma.
Human and Animal Cells Saos-2(RCB0428) Development of p53 protein transduction therapy using membrane-permeable peptides and the application to oral cancer cells.
Human and Animal Cells HGC-27(RCB0500) Human canalicular multispecific organic anion transporter (cMOAT) is expressed in human lung, gastric, and colorectal cancer cells.
Human and Animal Cells OVK18(RCB1903) Expression of Ferredoxin1 in cisplatin‑resistant ovarian cancer cells confers their resistance against ferroptosis induced by cisplatin.
Human and Animal Cells A549 The Glycosylated N-Terminal Domain of MUC1 Is Involved in Chemoresistance by Modulating Drug Permeation Across the Plasma Membrane.
Human and Animal Cells A549(RCB0098) Nrf2/p‑Fyn/ABCB1 axis accompanied by p‑Fyn nuclear accumulation plays pivotal roles in vinorelbine resistance in non‑small cell lung cancer.
Human and Animal Cells NEC8(RCB0489) Testis-expressed gene 11 inhibits cisplatin-induced DNA damage and contributes to chemoresistance in testicular germ cell tumor.
Human and Animal Cells WI-38 Abrogation of apoptosis induced by DNA-damaging agents in human bladder-cancer cell lines with p21/WAF1/CIP1 and/or p53 gene alterations.
Human and Animal Cells JHOS-2(RCB1521) , JHOS-4(RCB1678) Circular RNA circPBX3 promotes cisplatin resistance of ovarian cancer cells via interacting with IGF2BP2 to stabilize ATP7A mRNA expression.
Human and Animal Cells Colon-26(RCB2657) Introduction of Fluorine into Antitumor-Active Dinuclear Platinum(II) Complexes Leads to Modulation of In Vivo Antitumor Activity in Mice.
Human and Animal Cells TE-1(RCB1894) , TE-9(RCB1988) FAT1 downregulation enhances stemness and cisplatin resistance in esophageal squamous cell carcinoma.
Human and Animal Cells HHUA(RCB0658) Impact of the glutathione synthesis pathway on sulfasalazine-treated endometrial cancer.
Human and Animal Cells Ca9-22(RCB1976) Substituent effects of cyclic naphthalene diimide on G-quadruplex binding and the inhibition of cancer cell growth.